Whalen Kathleen M's Form 4 filing
HCA Healthcare, Inc. (HCA) · filed Feb 22, 2023
- Accession no.
- 0001209191-23-012010
- Filed
- Feb 22, 2023
- Trade date
- Feb 17, 2023
- Filing delay
- 5 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 3 non-derivative transactions and 0 derivative transactions. Open-market sales total $457.1K. It was filed 5 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Whalen Kathleen MCIK 0001763910 | Officer (SVP & Chief Ethics Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 17, 2023 | Common Stock | SSaleDisposed | −1,734 | $263.61 | −$457,099.74 | 9,962 | Direct | |
| Feb 17, 2023 | Common Stock | AGrant or awardAcquired | +4,560 | $0.00 | $0 | 14,522 | Direct | |
| Feb 17, 2023 | Common Stock | FTax withholdingDisposed | −1,356 | $262.84 | −$356,411.04 | 13,166 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.